Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 89 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | 0.0% | 149 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 149 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 149 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -50.0% | 149 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | +33.3% | 149 | +96.1% | 0.00% | – |
| Q2 2021 | $3,000 | +50.0% | 76 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | -50.0% | 76 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | -55.6% | 76 | -66.1% | 0.00% | – |
| Q3 2020 | $9,000 | +50.0% | 224 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | 0.0% | 224 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -14.3% | 224 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | – | 224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
| Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
| MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
| Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
| First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
| Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
| Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
| Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |